購物車
幫助
021-54845833/15800441009
|
Background: |
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. |
|
Applications: |
ELISA, IHC |
|
Name of antibody: |
SNCA |
|
Immunogen: |
Synthetic peptide of human SNCA |
|
Full name: |
synuclein, alpha (non A4 component of amyloid precursor) |
|
Synonyms： |
PD1; NACP; PARK1; PARK4 |
|
SwissProt: |
P37840 |
|
ELISA Recommended dilution: |
1000-2000 |
|
IHC positive control: |
Human brain and Human thyroid cancer |
|
IHC Recommend dilution: |
25-100 |
